HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.
Overview
Vikram Verghese, Chief Financial Officer of HeartFlow, Inc. (NASDAQ:HTFL), sold 33,416 shares in trades executed on September 2, 2026 and September 3, 2026. SEC Form 4 filing
Transaction value based on SEC Form 4 weighted average sale price ($49.85); post-transaction value based on September 3, 2026 market close ($49.71).
Details
HeartFlow operates as a global medical technology company headquartered in San Francisco. The company has demonstrated significant market momentum, with its stock appreciating 58.92% over the past twelve months, reflecting investor confidence in its innovative cardiac diagnostic platform.
Source
Originally published at www.fool.com.